Does VEDOLIZUMAB Cause Autoimmune hepatitis? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Autoimmune hepatitis have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.1% of all adverse event reports for VEDOLIZUMAB.
49
Reports of Autoimmune hepatitis with VEDOLIZUMAB
0.1%
of all VEDOLIZUMAB reports
0
Deaths
16
Hospitalizations
How Dangerous Is Autoimmune hepatitis From VEDOLIZUMAB?
Of the 49 reports, 16 (32.7%) required hospitalization.
Is Autoimmune hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Autoimmune hepatitis?
NIVOLUMAB (481)
ATORVASTATIN (357)
IPILIMUMAB (352)
PEMBROLIZUMAB (315)
ADALIMUMAB (237)
INFLIXIMAB (191)
ATEZOLIZUMAB (146)
METHOTREXATE (146)
NITROFURANTOIN (130)
PREDNISONE (107)
Which VEDOLIZUMAB Alternatives Have Lower Autoimmune hepatitis Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB